Menu

Blog

Mar 19, 2024

Don’t buy the hype on new “breakthrough” Alzheimer’s treatments

Posted by in categories: biotech/medical, neuroscience

Two new treatments for Alzheimer’s – lecanemab and donanemab – have been hailed as breakthroughs. In reality, they will have little effect.

Comments are closed.